“…Blockade of ICAM-1, LFA-1, and VLA-4 by monoclonal antibodies markedly inhibits spleen and granuloma cell interleukin (IL)2 and IL4 production -both cytokines being crucial for the initial events of schistosomal granuloma formation (Lukacs & Boros 1993, Wynn et al 1993) -as well as lymphoproliferative responses, both in the acute and chronic infection (Langley & Boros 1995). As infection ages, granulomas appear with a non-homogenous ICAM-1/LFA-1 staining pattern, in contrast to homogenous staining granulomas during acute infection (Jacobs et al 1997b). Whether this is due to the appearance of new cellular granuloma constituents that lack ICAM-1 or LFA-1 expression or that cellular expression is switched off in aging granulomas of previously immunoreactive cells is unclear, but since Langley and Boros (1995) did not observe apparent differences in the levels of expression of ICAM-1 and LFA-1 between acute-and chronic-infection granuloma derived cells, the appearance of new non-ICAM-1/LFA-1 immunoreactive cells in the granuloma co-existing with resident immunoreactive granuloma cells is most likely.…”